BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pinto VM, Forni GL. Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series. Int J Mol Sci 2020;21:E8771. [PMID: 33233561 DOI: 10.3390/ijms21228771] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 El Sehmawy AA, Hassan DA, Elamir RY, Eldesoky NA, Al Anany MGED, El-Fattah DAA, El Attar S, Abdelbadea A. Assessment of coagulation markers, serum zinc and copper in children with beta-thalassemia major in Egypt. J Trop Pediatr 2022;68:fmac079. [PMID: 36130309 DOI: 10.1093/tropej/fmac079] [Reference Citation Analysis]
2 Shoemaker ME, Salmon OF, Smith CM, Duarte-gardea MO, Cramer JT. Influences of Vitamin D and Iron Status on Skeletal Muscle Health: A Narrative Review. Nutrients 2022;14:2717. [DOI: 10.3390/nu14132717] [Reference Citation Analysis]
3 Alves FM, Kysenius K, Caldow MK, Hardee JP, Chung JD, Trieu J, Hare DJ, Crouch PJ, Ayton S, Bush AI, Lynch GS, Koopman R. Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy. J Cachexia Sarcopenia Muscle 2022;13:1541-53. [PMID: 35249268 DOI: 10.1002/jcsm.12950] [Reference Citation Analysis]
4 Entezari S, Haghi SM, Norouzkhani N, Sahebnazar B, Vosoughian F, Akbarzadeh D, Islampanah M, Naghsh N, Abbasalizadeh M, Deravi N, Abd Elhakim Y. Iron Chelators in Treatment of Iron Overload. Journal of Toxicology 2022;2022:1-18. [DOI: 10.1155/2022/4911205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Song S, Guo Y, Yang Y, Fu D. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther 2022;237:108168. [PMID: 35283172 DOI: 10.1016/j.pharmthera.2022.108168] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
6 Behl T, Madaan P, Sehgal A, Singh S, Anwer MK, Makeen HA, Albratty M, Mohan S, Bungau S. Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson's Disease. Int J Mol Sci 2022;23:678. [PMID: 35054862 DOI: 10.3390/ijms23020678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zhou X, Huang L, Wu J, Qu Y, Jiang H, Zhang J, Qiu S, Liao C, Xu X, Xia J, Lian Q. Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia. Biomed Pharmacother 2021;146:112548. [PMID: 34923340 DOI: 10.1016/j.biopha.2021.112548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Fedotcheva TA, Sheichenko OP, Fedotcheva NI. New Properties and Mitochondrial Targets of Polyphenol Agrimoniin as a Natural Anticancer and Preventive Agent. Pharmaceutics 2021;13:2089. [PMID: 34959369 DOI: 10.3390/pharmaceutics13122089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Taher AT, Cappellini MD. Luspatercept for β-thalassemia: beyond red blood cell transfusions. Expert Opin Biol Ther 2021;21:1363-71. [PMID: 34404288 DOI: 10.1080/14712598.2021.1968825] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sandnes M, Ulvik RJ, Vorland M, Reikvam H. Hyperferritinemia-A Clinical Overview. J Clin Med 2021;10:2008. [PMID: 34067164 DOI: 10.3390/jcm10092008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]